AGEN (AGEN) Stock Price & Analysis
AGEN (AGEN) rose 0.00% to USD 8.24 as of September 8, 2026 at 10:18 UTC, according to Nexqual real-time market data.
AGEN last closed at USD 8.24; the session ranged USD 7.99–8.38 on volume of 986,848 shares. Market capitalization is —, with a 52-week range of USD 2.71–8.85 (NCM). Source: Nexqual, September 8, 2026 at 10:18 UTC.
Key Statistics (as of September 8, 2026 at 10:18 UTC)
| Price | USD 8.24 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 8.24 |
| Open | USD 8.24 |
| Day Range | USD 7.99 – 8.38 |
| 52-Week Range | USD 2.71 – 8.85 |
| Volume | 986,848 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (AGEN)
Nexqual's technical model rates AGEN "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 10:18 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 61.64 (neutral) |
| vs SMA50 | Above (USD 6.28) |
| MACD | 0.48 (positive) |
From AGEN's Latest SEC 10-K Filing (filed 2026-03-16)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals, Inc. | USD 9.96 | ▼ 2.06% |
| GERN | Geron Corporation | USD 1.57 | ▼ 1.26% |
| CRIS | Curis, Inc. | USD 1.35 | ▼ 2.17% |
| CLDX | Celldex Therapeutics, Inc. | USD 39.68 | ▲ 0.51% |
| ACAD | ACADIA Pharmaceuticals Inc. | USD 28.02 | ▼ 3.15% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:18 UTC. This page is informational and not investment advice.